πŸ‡ΊπŸ‡Έ FDA
Patent

US 8338624

Isoflavone derivatives and uses thereof

granted A61PA61P19/00A61P25/00

Quick answer

US patent 8338624 (Isoflavone derivatives and uses thereof) held by Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P19/00, A61P25/00, A61P3/04, A61P35/00